Latest filing published 12 Dec 2016 for Valeant Pharmaceuticals International, Inc., €188k.
Robert Rosiello discloses dealings in Valeant Pharmaceuticals International, Inc. to SEDI. The record holds 6 filings, for trades running from 20 July 2016 to 5 December 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 12 December 2016: a transaction of €188k, in Valeant Pharmaceuticals International, Inc. Between a trade and the moment it shows up on SEDI, the median delay is 7 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations